Are you Dr. Ashfaq?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 19 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6655 N MacArthur Blvd
Irving, TX 75039Phone+1 214-277-8700Fax+1 214-596-7484
Summary
- Dr. Raheela Ashfaq, MD is a board certified pathologist in Irving, Texas. She is currently licensed to practice medicine in Texas, Wyoming, and Utah.
Education & Training
- University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 1989 - 1991
- Fatima Jinnah Medical CollegeClass of 1982
Certifications & Licensure
- FL State Medical License 2012 - 2026
- WV State Medical License 2014 - 2026
- VA State Medical License 2017 - 2026
- MA State Medical License 2014 - 2026
- MD State Medical License 2014 - 2026
- UT State Medical License 2021 - 2026
- MO State Medical License 2014 - 2026
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
- Join now to see all
Publications & Presentations
PubMed
- 218 citationsWhole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical Pathology: A Multicenter Blinded Randomized Noninferiority Study of 1992 Cases (Pivotal Study).Sanjay Mukhopadhyay, Michael Feldman, Esther Abels, Raheela Ashfaq, Senda Beltaifa
The American Journal of Surgical Pathology. 2017-09-01 - 399 citationsBevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Grou...Robert L. Coleman, Mark F. Brady, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong
The Lancet. Oncology. 2017-06-01 - 45 citationsTumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatmentD. Pouessel, Y. Neuzillet, Laura S. Mertens, M.S. van der Heijden, J. De Jong
Annals of Oncology. 2016-04-18